Close
American Drug Delivery & Formulation Summit
Xylem

Business & Industry

Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool

Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant's field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi's field agents faster, more efficient...

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in...

Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal

Eli Lilly has entered into a multi-program collaboration with Beijing-based Haisco Pharmaceutical Group, committing an upfront payment of $87 million and exposing itself to up to $2.97 billion in potential milestone payments. The total value of the arrangement could...

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially finalized a comprehensive licensing agreement. Under the terms of the worldwide arrangement, Sonefpeglutide licensing is for global development, manufacturing, and commercialization, excluding the South Korean market. The financial framework includes...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing a global licensing and collaboration agreement valued at up to $10.5 billion. The transaction focuses on the research, development, and commercialization of 12 early-stage oncology programs. This arrangement combines the...

Nestlรฉ and IdB Partner to Bring rCDI Preventive Therapy to Europe

Nestlรฉ Health Science and IdB Holding have officially announced a VOWST licensing agreement to develop and commercialize the oral therapy in Europe, subject to approval by the European Medicines Agency (EMA). This collaboration aims to expand European patient access...

CordenPharma Seals AmbioPharm Deal to Expand Global Network

CordenPharma, a global contract development and manufacturing organization specializing in complex drug modalities, has officially entered into an agreement to acquire AmbioPharm. The AmbioPharm Deal strengthens the companyโ€™s manufacturing presence in the United States while adding newly integrated production...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป